Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Controlled Trial of an Electronic Decision Aid for Genetic Testing in Inherited Cancer Syndromes

NCT05470920 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT05470920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05470920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Controlled Trial of an Electronic Decision Aid for Genetic Testing in Inherited Cancer Syndromes
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Completed
Start date
October 14, 2022
Completion date
May 19, 2026
Enrollment
297 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

epithelial ovarian carcinoma, pancreas adenocarcinoma